MERIGHI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 12.684
EU - Europa 3.922
AS - Asia 2.180
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 6
AF - Africa 2
Totale 18.808
Nazione #
US - Stati Uniti d'America 12.670
CN - Cina 1.403
UA - Ucraina 961
DE - Germania 877
TR - Turchia 683
IT - Italia 602
GB - Regno Unito 391
SE - Svezia 333
FI - Finlandia 213
PL - Polonia 154
BE - Belgio 143
RU - Federazione Russa 121
FR - Francia 57
HK - Hong Kong 38
AT - Austria 26
NL - Olanda 14
VN - Vietnam 13
IN - India 11
CA - Canada 9
CZ - Repubblica Ceca 8
IR - Iran 7
AU - Australia 6
EU - Europa 6
ES - Italia 5
MX - Messico 5
CL - Cile 4
JP - Giappone 4
SG - Singapore 4
CH - Svizzera 3
IL - Israele 3
KR - Corea 3
TW - Taiwan 3
BD - Bangladesh 2
DZ - Algeria 2
GR - Grecia 2
IM - Isola di Man 2
IQ - Iraq 2
NO - Norvegia 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
IE - Irlanda 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 18.808
Città #
Woodbridge 1.755
Fairfield 1.554
Jacksonville 1.091
Chandler 1.076
Houston 1.036
Ann Arbor 878
Ashburn 758
Seattle 649
Wilmington 639
Cambridge 532
Izmir 364
Nanjing 334
Beijing 295
Ferrara 255
Princeton 255
Boardman 176
Warsaw 154
Milan 148
Brussels 142
Dearborn 126
San Diego 114
Shenyang 110
Nanchang 105
Shanghai 93
Addison 90
Bremen 82
New York 73
Hebei 64
Tianjin 64
Changsha 61
Jiaxing 45
San Mateo 43
Jinan 41
Falls Church 39
Hong Kong 37
Mountain View 35
Kunming 34
Norwalk 32
Philadelphia 31
Zhengzhou 31
Auburn Hills 26
London 25
Redwood City 25
Ningbo 24
Chicago 21
Des Moines 20
Orange 19
Guangzhou 18
Vienna 18
Lanzhou 16
Tappahannock 14
Bologna 13
Hefei 13
Verona 13
Washington 13
Dong Ket 12
Ferrara di Monte Baldo 12
Hangzhou 12
Redmond 12
Taizhou 12
Indiana 10
Helsinki 9
Los Angeles 9
Haikou 8
Augusta 7
Düsseldorf 7
Hounslow 7
Edinburgh 6
Kilburn 6
Padova 6
New Bedfont 5
Ardabil 4
Brno 4
Pune 4
San Francisco 4
Adelaide 3
Amsterdam 3
Bari 3
Calderara Di Reno 3
Changchun 3
Frankfurt am Main 3
Istanbul 3
Lappeenranta 3
Lequile 3
Marseille 3
Montreal 3
Mysore 3
Sevilla 3
Taipei 3
Tokyo 3
Valdivia 3
Véry 3
Acton 2
Andover 2
Ariano nel Polesine 2
Bergamo 2
Camerino 2
Chiswick 2
Douglas 2
Este 2
Totale 13.942
Nome #
A glance at adenosine receptors: Novel target for antitumor therapy 197
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 186
The A3 adenosine receptor: history and perspectives 158
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 151
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 151
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 149
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 149
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 139
Adenosine receptors and human melanoma 138
Pathological overproduction: the bad side of adenosine 138
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 134
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 131
Pharmacology of Adenosine Receptors: The State of the Art 130
Adenosine receptor targeting in health and disease 129
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 129
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 125
null 125
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 125
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 123
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 119
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 118
null 118
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 118
Adenosine receptors and cancer 117
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 117
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 116
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 115
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 115
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 114
null 113
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 113
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 113
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 112
null 112
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 111
New potent and selective human adenosine A3 receptor antagonists. 111
The A3 adenosine receptor: an enigmatic player in cell biology. 110
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 109
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 109
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 108
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 108
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 108
null 107
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 106
Adenosine receptors in health and disease 106
Agonists and antagonists: Molecular mechanisms and therapeutic applications 106
null 106
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 105
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 104
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 104
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 104
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 104
Adenosine and lymphocyte regulation 104
A(2A) adenosine receptors in human peripheral blood cells 103
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 102
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 102
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 102
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 102
null 102
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 102
null 102
van't Hoff Based Thermodynamics 102
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 101
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 101
Adenosine A2A receptors in human circulating blood elements 100
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 100
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 100
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 100
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 99
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 98
PKCε as a novel promoter of skeletal muscle differentiation and regeneration 98
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 98
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 97
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 97
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 97
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 96
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 95
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 95
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 94
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells 94
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 93
Glucocorticoids' pharmacology: Past, present and future 92
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 91
New potent and selective human adenosine A3 receptor antagonists 91
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 90
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 90
null 90
null 90
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors. functional and biochemical aspects 89
null 89
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 88
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 88
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 87
null 86
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment 86
Caffeine alters the A2A adenosine receptors and their function in human platelets 86
Totale 11.058
Categoria #
all - tutte 60.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.437
Totale 62.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.124 0 0 0 0 0 0 0 0 215 439 508 962
2019/20204.010 688 116 106 544 246 494 379 417 319 433 207 61
2020/20213.065 281 309 129 367 149 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.632 245 223 91 337 424 325 158 229 293 28 188 91
2023/2024846 119 209 47 36 143 139 53 93 7 0 0 0
Totale 19.104